Faeth Therapeutics, Inc. (FTH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$19.16

From 52W high−51.46%

Volume350610.00

Market cap$502.34M

P/E (TTM)—

P/S (TTM)−103.6x

Div yield—

Key dataOct 19, 2026

Open

$19.16

From 52W high

−51.46%

Volume

350610.00

Market cap

$502.34M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.6x

P/E (TTM)

—

RSI (14)

26.9

MomentumView details →

1D Return

+3.40%

YTD Return

+80.18%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−1.6x

EV/Sales

−65.2x

P/S (TTM)

−103.6x

P/B (TTM)

2.9x

ProfitabilityView details →

Gross Margin

2740.82%

Net Margin

4030.69%

EBITDA Margin

4027.99%

ROE (TTM)

−113.05%

ROA (TTM)

−103.29%

Asset Turnover

−0.02x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+30.36%

EBITDA YoY

—

MomentumView details →

1D Return

+3.40%

YTD Return

+80.18%

1Y Return

+74.46%

RSI (14)

26.9

vs 50D SMA

−37.93%

vs 200D SMA

−22.42%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

19.69x

Quick Ratio

19.69x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$2.84

EPS Surprise

−7.58%

Beats (12Q)

0/12

Next Q EPS Est

−$0.77

Avg Surprise (4Q)

−7.58%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

−4.85M

Net Income (TTM)

−195.53M

Op. CF (TTM)

−33.86M

Next earningsNov 13, 2026 →

Latest newsMore news →

No recent news for FTH.

Similar companies

XOMA Royalty Corp.XOMA CytomX Therapeutics, Inc.CTMX Entera Bio Ltd.ENTX Neurogene Inc.NGNE Valneva SEVALN Monopar Therapeutics Inc.MNPR Find similar companies →

Latest newsMore news →

No recent news for FTH.